Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
Clinical trial NCT06880770 · RECRUITING
Trial details
- NCT number
- NCT06880770
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-24
- Primary completion
- 2029-03-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.